CVS Health Corp. (NYSE:CVS) experienced a 14.95% surge on Wednesday, reaching $63.22 per share, as investors reacted positively to the company’s optimistic outlook for its performance in 2025.
According to CEO David Joyner, CVS aims to deliver better care for consumers while improving outcomes and reducing costs. This statement came despite mixed earnings results in the fourth quarter of 2024, which showed a 28% decrease in net income to $1.6 billion and a 45% decline in full-year 2024 profits to $4.59 billion.
However, CVS’s revenue grew by 4% year-over-year, reaching $97.7 billion in the last three months of 2024. This growth was accompanied by an increase in revenues for 2024 to $372 billion.
With this surge, CVS ranks fourth on our list of top-performing stocks on Wednesday. While the company’s stock has shown promise, Insider Monkey recommends considering AI stocks with greater potential for higher returns and shorter investment periods.
Source: https://finance.yahoo.com/news/why-cvs-health-corp-cvs-132435049.html